Reduction of Anticancer Drug Toxicity - Contributions to Oncology
Latest Publications

TOTAL DOCUMENTS

25

(FIVE YEARS 0)

H-INDEX

2

(FIVE YEARS 0)

Published By S. Karger AG

9783805560429, 9783318034318

Latest Documents Most Cited Documents Contributed Authors Related Sources Related Keywords

Subject Index

Reduction of Anticancer Drug Toxicity - Contributions to Oncology ◽

10.1159/000424058 ◽

1995 ◽

pp. 207-210

Download Full-text

Antibody-Directed Enzyme Prodrug Therapy

Reduction of Anticancer Drug Toxicity - Contributions to Oncology ◽

10.1159/000424051 ◽

1995 ◽

pp. 148-159

Author(s):

Richard J. Knox

Keyword(s):

Enzyme Prodrug Therapy

Download Full-text

Trans-Dominant Inhibition of Poly(ADP-Ribosyl)ation: A Novel Approach toward Tumor Cell Sensitization

Reduction of Anticancer Drug Toxicity - Contributions to Oncology ◽

10.1159/000424050 ◽

1995 ◽

pp. 142-147

Author(s):

Jan-Heiner Küpper ◽

Marcus Müller ◽

Alexander Bürkle

Keyword(s):

Download Full-text

Transfer of Genes Affecting Resistance of Mammalian Cells to Alkylating Drugs — Implications for Cancer Chemotherapy

Reduction of Anticancer Drug Toxicity - Contributions to Oncology ◽

10.1159/000424049 ◽

1995 ◽

pp. 125-141 ◽

Author(s):

Bernd Kaina ◽

Gerhard Fritz ◽

Erik Eschbach ◽

Jörg Dosch ◽

Ilka Preuss

Keyword(s):

Cancer Chemotherapy ◽

Mammalian Cells ◽

Alkylating Drugs

Download Full-text

Effect of Amifostine on Antitumour Activity and Pharmacokinetics of Carboplatin1

Reduction of Anticancer Drug Toxicity - Contributions to Oncology ◽

10.1159/000424041 ◽

1995 ◽

pp. 63-71

Author(s):

A. E. C. Korst ◽

W. J. F. van der Vijgh ◽

E. Boven ◽

C. M. Eeltink ◽

A. M. Fichtinger-Schepman ◽

...

Keyword(s):

Antitumour Activity

Download Full-text

Plasminogen Activator Activities in Human Tumor Xenografts and Their Exploitation for Selective Activation of Prodrugs by Plasmin

Reduction of Anticancer Drug Toxicity - Contributions to Oncology ◽

10.1159/000424055 ◽

1995 ◽

pp. 189-194 ◽

Author(s):

S. Lauck-Birkel ◽

W. C. Tang ◽

B. Wagner ◽

H. H. Fiebig ◽

D. Kohlmüller ◽

...

Keyword(s):

Plasminogen Activator ◽

Human Tumor ◽

Selective Activation ◽

Human Tumor Xenografts ◽

Tumor Xenografts

Download Full-text

Flow-Cytometric Analysis of Myeloid and Lymphoid Cell Subsets following Cytokine-Mediated ex vivo Maturation of Peripheral Blood Stem Cells

Reduction of Anticancer Drug Toxicity - Contributions to Oncology ◽

10.1159/000424046 ◽

1995 ◽

pp. 105-111 ◽

Author(s):

Raimund Höft ◽

Stefan Fruehauf ◽

Rainer Haas ◽

Werner Hunstein ◽

Walter Jens Zeller

Keyword(s):

Peripheral Blood ◽

Lymphoid Cell ◽

Ex Vivo ◽

Flow Cytometric Analysis ◽

Peripheral Blood Stem Cells ◽

Flow Cytometric ◽

Blood Stem Cells

Download Full-text

Effect of Testosterone on Normal and Malignant Hematopoietic Stem Cells of the Rat Exposed to Et-18-OCH3

Reduction of Anticancer Drug Toxicity - Contributions to Oncology ◽

10.1159/000424057 ◽

1995 ◽

pp. 202-206

Author(s):

R. Groβelfinger ◽

W. J. Zeller

Keyword(s):

Hematopoietic Stem Cells ◽

Hematopoietic Stem

Download Full-text

Comparison of CD34 Selection and B-Cell Depletion for Lymphoma Cell Purging from Leukapheresis Products

Reduction of Anticancer Drug Toxicity - Contributions to Oncology ◽

10.1159/000424047 ◽

1995 ◽

pp. 112-117

Author(s):

Mike Haberkorn ◽

Stefan Fruehauf ◽

Rainer Haas ◽

Werner Hunstein ◽

Walter Jens Zeller

Keyword(s):

B Cell ◽

Lymphoma Cell ◽

Cell Depletion ◽

B Cell Depletion ◽

Download Full-text

Chemoprotective Effects of Amifostine on Hematopoietic and Nonhematopoietic Tissue

Reduction of Anticancer Drug Toxicity - Contributions to Oncology ◽

10.1159/000424040 ◽

1995 ◽

pp. 53-62

Author(s):

W. Oster ◽

B. Scheffler ◽

P. Schein ◽

R. Capizzi

Download Full-text